HSV-NIS, an oncolytic herpes simplex virus type 1 encoding human sodium iodide symporter for preclinical prostate cancer radiovirotherapy

Several clinical trials have shown that oncolytic herpes simplex virus type 1 (oHSV-1) can be safely administered to patients. However, virus replication in tumor tissue has generally not been monitored in these oHSV clinical trials, and the data suggest that its oncolytic potency needs to be improv...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Li, H, Nakashima, H, Decklever, T D, Nace, R A, Russell, S J
Formato: Artigo
Idioma:Inglês
Publicado: Nature Publishing Group 2013
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3747331/
https://ncbi.nlm.nih.gov/pubmed/23868101
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cgt.2013.43
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares